Of greater concern are potential risks from combination use: Hypoglycaemia risk: Retatrutide enhances insulin secretion in a glucose-dependent manner, which carries a low intrinsic hypoglycaemia risk when used alone
Many individuals continue using supplements throughout their time on GLP-1 medications to help support hydration, protein intake, and overall nutrition consistency
Over the past few years, GLP-1 receptor agonists have moved from diabetes treatment rooms to mainstream weight management conversations, and for good reason
The MSC: an injury drugstore
Timeline of Retatrutide Results: Week by Week The trial data shows weight loss beginning early and continuing throughout treatment
Unalp-Arida A, Ruhl CE (2023) Increasing gallstone disease prevalence and associations with gallbladder and biliary tract mortality in the US